Stereotactic Ablative Radiotherapy (SABR) one stop service for lung cancer: A pilot study for early-stage Non-Small-Cell Lung Cancer (NSCLC)
- Author(s)
- Wallace, ND; Burns, M; Devereux, T; Moran, B; Yeo, A; Hardcastle, N; Panettieri, V; Kaur, J; Barber, J; Rahim, S; Diery, J; Lee, L; Woodford, K; Duffy, M; deDios, B; Plumridge, N; MacManus, M; Siva, S; Shaw, M; Harden, S;
- Journal Title
- Radiotherapy and Oncology
- Publication Type
- Research article
- Abstract
- BACKGROUND: Single-fraction stereotactic ablative radiotherapy (SABR) is a curative treatment option for patients with early lung cancer. We undertook a feasibility study to assess whether simulation, planning and treatment could be undertaken within a single day and whether this expedited pathway was acceptable to patients. METHODS: A multidisciplinary team of radiation oncologists, radiation therapists and medical physicists developed a workflow to permit all aspects of planning and treatment to be conducted within a single working day. All aspects of the pathway were timed. Prescription dose was 30 Gray. Patients completed an Experience Survey within two weeks of treatment. The study would be deemed successful if it met both dual primary endpoints of feasibility (7/10 patients treated within 8 working hours) and patient satisfaction (7/10 expressing overall satisfaction). RESULTS: Ten patients were treated. These included 6 women and 4 men. Median age was 76.5 and 9 patients had been deemed to be medically inoperable. Median time from commencement of CT simulation to end of treatment was h 50 min (IQR 6 h 42 m - 7 h 4 m); 9/10 patients were treated within the target 8-hour window. All 10 patients expressed overall satisfaction with the service. All 10 felt it was more convenient than our usual treatment pathway would have been. CONCLUSION: Same-day single-fraction SABR is feasible and acceptable to patients. This pathway should be considered for those who live a significant distance from treatment centres or who have other difficulties in attending for multiple visits.
- Publisher
- Elsevier
- Keywords
- Nsclc; Patient satisfaction; Sabr; Same-day Sim-plan-and-treat SABR; Single-fraction SABR
- Department(s)
- Radiation Oncology; Radiation Therapy; Physical Sciences; Nursing; Biostatistics and Clinical Trials
- Publisher's Version
- https://doi.org/10.1016/j.radonc.2026.111553
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-05-21 04:00:18
Last Modified: 2026-05-21 04:00:28